The sodium^proton exchanger is activated by various agonists, including insulin, even in human red blood cell. MAPKinase, a family of ubiquitous serine/threonine kinases, plays an important role in the signal transduction pathways which lead to sodium^proton exchanger activation. The aim of our study was to establish the existence of MAPKinase in human red blood cell and to investigate the effects of its activation by insulin and okadaic acid on the sodium^proton exchanger. Immunoblot with antiMAPK antibody revealed the presence of two isoforms, p44 ERK1 and p42 ERK2 . Insulin stimulated MAPKinase activity and increased the phosphorylation of MAPK tyrosine residues, with a peak time between 3 and 5 min. Okadaic acid, an inhibitor of serine/threonine phosphatases, stimulated MAPKinase activity. In the presence of PD98059, an inhibitor of MEK, the upstream activator of MAPKinase, insulin and okadaic acid failed to stimulate MAPKinase. Insulin and okadaic acid increased the activity of the sodium^proton exchanger and this effect was abolished by PD98059. In conclusion, we first describe the presence and activity of MAPKinase in human red blood cell. Furthermore, we demonstrate that in human red blood cell, insulin modulates the sodium^proton exchanger through MAPKinase activation. ß
Introduction
The sodium^proton exchanger is a plasma membrane glycoprotein which mediates the exchange of intracellular H for extracellular Na with a 1:1 stoichiometry [1] . Several isoforms of the protein have been identi¢ed and are designed as NHE-1 to -5 [2] . The Na /H exchanger isoform 1 (NHE-1) is an ubiquitous membrane transporter that has an important role in the regulation of cell pH (pH i ), cell volume and cell proliferation. NHE-1 is activated by a wide variety of stimuli, including growth factors, phorbol esters, insulin, hormones, and it is regulated by several intracellular kinases such as Ca 2 -calmodulin, cAMP-dependent kinase, protein kinase C and the mitogen-activated protein kinases (MAPK) [3, 4] .
The presence of a tightly coupled sodium/hydrogen exchange (NHE) has been well documented in human red blood cells (RBC) [5] . The internal cytosolic amino acid sequence of NHE isoform 1 (NHE1) was demonstrated in human RBC with immunoblot assay [6] . Other NHE isoforms are not expressed in human reticulocytes and RBC [7] .
Ceolotto et al. have demonstrated that in human RBC, NHE is activated by phorbol esters and by insulin through di¡erent pathways [8] . The phorbol ester PMA stimulates NHE by activation and translocation of PKC from the cytosol to the membrane, while insulin activates NHE by PKC-independent mechanisms. Furthermore, immunoprecipitation assays of NHE-1 in RBC treated with insulin showed an increased NHE-1 phosphorylation [9] . However, the mechanism underlying NHE-1 activation by insulin in RBC is as yet unknown.
Recent studies in vascular smooth muscle cells (VSMC) [10] , in platelets [11] , and in lymphoblasts [12] , have shown that MAPK is involved in NHE-1 regulation. MAPK, a family of ubiquitous Ser/Thr kinases, plays an important role in various signal transduction pathways, including insulin, growth factors, tumor promoters, cytokines, osmotic shock and stress [13] . In mammalian cells, the ¢rst and best characterized MAPK isoforms are p44 ERK1 and p42 ERK2 both of which are essential for intracellular transduction signals of growth factors and insulin [14] .
Therefore, the purpose of the present study was to establish the presence of the p44 ERK1 and p42
ERK2
MAPK isoforms in human RBC, and to describe their role in the regulation of NHE.
Materials and methods

Subject selection
Blood samples were drawn from 11 healthy, lean, normotensive subjects, aged 25^45 years, after an overnight fast.
Materials
Protease inhibitors, ATP, EDTA, ouabain, neptazane, methazolamide, DIDS, bumetanide, Tris, MOPS, HEPES, MES, nystatin, dithitheitrol, sodium dodecyl sulfate, albumin were purchased from Sigma (St. Louis, MO). MAPK antibodies were purchased from Santa Cruz Biotechnology. Porcine insulin, reagents for the MAPK assay, MAPK-selective substrate were obtained from Calbiochem (La Jolla, CA). [Q-32 P]ATP, nitrocellulose membranes were obtained from Amersham (Buckinghamshire, UK). Acationox detergent was obtained from American Scienti¢c Products (Boston, MA). The speci¢c MEK inhibitor PD98059 and okadaic acid were from Calbiochem (La Jolla, CA).
Preparation of red blood cells
Blood was drawn into heparinized tubes and centrifuged at 3000 rpm for 4 min at 4³C. Plasma and bu¡y coat were removed by aspiration, and red blood cells washed three times with ice-cold washing solution (CWS) that contained (mmol l 31 ): choline chloride 149, MgCl 2 1, Tris-MOPS 10, pH 7.4 (4³C).
Immunoblot analysis of MAPKinase isoforms
Red blood cells were immunoblotted with rabbit polyclonal antibody against MAPK carboxyl-terminal epitope (residues 349^361). RBC were lysed and dissolved in Laemmli bu¡er [15] . The proteins from RBC were separated by electrophoresis through a 10% polyacrylamide gel. Proteins separated on the gel were electroblotted onto nitrocellulose membrane in blotting bu¡er containing (mmol l 31 ): Tris 48, glycine 39, pH 8.3, 0.037% SDS in 20% (v/v) methanol for 2 h at 100 V in the cold, using a Bio-Rad Transblot cell. The nitrocellulose membrane was blocked overnight at 4³C in phosphate-bu¡ered saline (PBS) containing 0.05% (v/v) Tween and 5% bovine serum albumin (BSA). The nitrocellulose membranes were exposed to primary antibody (1:1500 dilution) for p44 ERK1 and p42 ERK2 overnight at 4³C. The nitrocellulose membranes were washed (four times for 20 min) with the same bu¡er and then incubated for 1 h at room temperature with 1:4000 goat anti-rabbit antibody conjugated to horseradish peroxidase. Membranes were washed four times with the same bu¡er, and detection was made using enhanced chemiluminescence system (ECL, Amersham).
Immunoblot analysis of tyrosine-phosphorylated MAPK
MAPK is active when phosphorylated on both threonine and tyrosine residues. To investigate the e¡ect of insulin on MAPK activation, we used phos-pho-speci¢c MAPK antibody. Washed RBC were incubated at 37³C in a incubation medium containing (mmol l 31 ): 150 KCl, 1.0 MgCl 2 , 5.0 glucose, 1.0 CaCl 2 , 20 Tris-MOPS pH 7.4, albumin 0.1% in the presence or absence of insulin (100 nM). Lysed RBC were electroblotted onto nitrocellulose membranes, and then blocked overnight at 4³C in phosphate-bu¡ered saline (PBS) containing 0.05% (v/v) Tween and 5% bovine serum albumin (BSA), and then immunoblotted with the phospho-speci¢c MAPK antibody (1:1000 dilution). This monoclonal antibody detects only Thr-202^Tyr-204-phosphorylated MAPK.
Detection was made with ECL as described earlier. Blots were scanned and quanti¢ed with a Bio-Rad Chemiluminescence Molecular Imaging Systems, and the results were compared to the control readings, on the same blot, set to 100%.
MAPK activity
The activity of MAPK was assayed by measuring the rate of [ 32 P]phosphate incorporation from [Q-32 P]ATP using saturating concentrations of the MAPK-selective substrate APRTPGGRRR, derived from bovine myelin basic protein [16] . Washed RBC were incubated for 30 min at 37³C in an incubation medium containing (mmol l 31 ): 150 KCl, 1.0 MgCl 2 , 5.0 glucose 1.0 CaCl 2 , 20 Tris-MOPS pH 7.4, albumin 0.1% in the presence or absence of 100 WM PD98059. Thereafter insulin (100 nM for 1, 3, 5, 10 or 15 min) or okadaic acid (1 WM for 20 min) were added to the incubation medium. Cells were lysed with 1 ml of lysis bu¡er, containing (mmol l 31 ): Tris-HCl 20, EGTA 2, EDTA 2, sodium £uo-ride 0.1, sodium orthovanadate 1, PMSF 1, aprotinin 20 Wg ml 31 , leupeptin 20 Wg ml 31 , pH 7.5) and were centrifuged at 12 000 rpm for 10 min at 4³C. The standard assay mixture (¢nal volume 40 Wl) contained (mmol l 31 ): Tris-HCl 12.5, pH 7.4, EGTA 2, MgCl 2 10, PKI (protein kinase A inhibitor) 50 mg ml 31 , 0.4 mg ml 31 of peptide, and [Q-32 P]ATP (500 000 cpm/10 Wl). Lysates (20^50 Wg of protein) were added to this mixture. After 15 min of incubation at 25³C, the reaction was stopped with 10 Wl of diluted trichloroacetic acid. A 40-Wl aliquot of the reaction media was spotted on a phosphocellulose paper (2.5U2.5 cm) (Whatman P81). The paper was washed four times for 10 min, with stirring, in phosphoric acid, dried, and assayed for 32 P by scintillation counting. MAPK assay was linear for 20 min.
MAPK activity was calculated as di¡erence between the 32 P incorporation in the presence and in the absence of substrate. Data were expressed as pmol of 32 P incorporated into peptide per mg of protein per min.
The protein concentration was measured by the method of Lowry et al. [17] , using bovine serum albumin as standard.
Measurement of NHE
NHE was estimated as net Na in£ux driven by an outward H gradient [8] .
Preparation of RBC
Blood was drawn into heparinized tubes and centrifuged at 3000 rpm for 4 min at 4³C. Plasma and bu¡y coat were removed by aspiration, and the RBC washed three times with ice-cold washing solution (CWS) that contained (mmol l 31 ): choline chloride 149, MgCl 2 1, Tris-MOPS 10, pH 7.4 (4³C). The RBC were then resuspended to approximately 50% hematocrit with CWS. Aliquots of this suspension were then used for determination of hematocrit, hemoglobin (optical density at 540 nm), and Na concentration (atomic absorption spectrophotometry) after appropriate dilution with 0.02% Acationox detergent in double-distilled water.
Modi¢cation of cell cation content
The nystatin procedure was used to prepare sodium-depleted cells. All solutions were prepared with deionized, double-distilled water, and the osmolarity was checked using a freezing point osmometer. Washed, packed cells were incubated at 15% hematocrit in cold nystatin loading solution (NLS) containing 40 Wg ml 31 nystatin for 20 min at 4³C and protected from light. Nystatin was dissolved in dimethyl sulfoxide (5 mg in 1.3 ml). For Na depletion, NLS contained (mmol l 31 ): KCl 150, sucrose 50. The cell suspension was then warmed to 37³C for 5 min, and the red blood cells washed four times with warm nystatin washing solution (NWS). NWS had the same composition as the NLS with the pH ad-justed to 7.4 with 1 mmol l 31 KH 2 PO 2 bu¡er and 10 mmol l 31 glucose and 0.1% albumin added. Removal of nystatin from the membrane was checked in every experiment by measurements of the passive permeability to Na .
Modi¢cation of RBC pH i
Na -depleted cells (5% hematocrit) were incubated at 37³C for 10 min in acid-loading solutions, which contained (mmol l The supernatant was carefully removed by aspiration and the external surface of the tubes wiped dry to eliminate Na contamination. The bottom of the tube, containing the cell pellet, was then cut o¡ and placed into 1 ml of 0.02% Acationox to lyse the cells. The cell lysates were vortexed vigorously and centrifuged at 2000Ug for 5 min at 4³C, and the hemoglobin concentration determined after diluting the lysate with 0.02% Acationox. The lysate Na concentration was determined by atomic absorption spectrophotometry and the cell Na content calculated by relating the optical density of the lysate to the hematocrit and optical density of the fresh cell suspension. Net Na in£ux was expressed as mmol l 31 cell h 31 .
Insulin, okadaic acid and PD98059 incubation experiments
To study the e¡ects of insulin, okadaic acid, PD98059, aliquots of washed RBC were incubated for 30 min at 37³C in an incubation medium containing (mmol l 31 ): 150 KCl, 1.0 MgCl 2 , 5.0 glucose. 1.0 CaCl 2 , 20 Tris-MOPS pH 7.4, albumin 0.1%, in the presence or absence of 100 WM PD98059. Insulin (100 nM) or okadaic acid (1 WM) were then added to the incubation medium for 20 min and to each of the acid loading, sodium depleting and in£ux media. Sodium depletion, acid load and sodium in£ux were conducted according to the same experimental protocol reported above.
Statistical analysis
The statistical analysis was performed with non parametric tests. Linear regression analysis was also used, when indicated. A P-value 6 0.05 was accepted as statistically signi¢cant. Data are presented as mean þ standard error (S.E.M.).
Results
Identi¢cation and activation of MAPK in human RBC
As shown in Fig. 1 , immunoblot analysis revealed the presence of two characteristic bands of 44 and 42 kDa, respectively, corresponding to p44 ERK1 and p42 ERK2 MAPK isoforms. MAPK is active when both threonine and tyrosine residues are phosphorylated. To investigate the e¡ect of insulin on MAPK activation we used a phosphospeci¢c MAPK antibody. As shown in Fig. 2 , the immunoblot analysis detected the presence of only one band of 44 kDa, corresponding to the phosphorylated MAPK isoform. Quantitative analysis, performed by scanning densitometry, showed that exposure of RBC to 100 nM insulin caused a rapid and transient phosphorylation of MAPKinase. The maximal increase (48 þ 5%, n = 3) occurred at 3 min, returning to the baseline at 10 min. We measured MAPK activity in lysates from cells treated with 100 nM insulin, using a speci¢c peptide as a substrate. As shown in Fig. 3 , the time course for activation of MAPK by insulin indicated that MAPK activity peaked within 3^5 min, and reached baseline at 10 min.
In order to verify the speci¢city of insulin-induced MAPK activation, the cells were treated for 30 min with PD98059 (100 WM), the inhibitor of MEK (the kinase capable of MAPK phosphorylation and activation), before being stimulated by insulin. PD98059 completely abolished the e¡ect of insulin on MAPK activity (Fig. 4) .
Similar responses were found in RBC treated for 20 min with 1 WM okadaic acid, a serine/threonine phosphatase inhibitor. As shown in Fig. 5 , okadaic acid markedly increased MAPK activity (from 0.62 þ 0.13 to 3.02 þ 1.51 pmol min 31 mg protein 31 , P 6 0.01). PD98059 (100 WM for 30 min) inhibited okadaic stimulation (from 3.02 þ 1.51 to 1.56 þ 0.52 pmol min 31 mg protein 31 P 6 0.01) (Fig. 5) . On the contrary, Na -depletion with nystatin and cellular acidi¢cation did not alter MAPK activity (data not shown).
E¡ect of MAPK activation on NHE activity
As previously reported, NHE activity was increased by insulin and okadaic acid [8] . As shown in Fig. 6 , we con¢rmed that insulin (100 nM) and okadaic acid (1 WM) enhance NHE activity from 17 þ 2 to 38 þ 9 mmol l 31 cell h 31 , P 6 0.05 and 17 þ 2 to 40 þ 7 mmol l 31 cell h 31 , P 6 0.05, respectively. After incubation with PD98059 (100 WM for 30 min) the e¡ect of insulin and okadaic acid on NHE activity was completely inhibited (Fig. 6 ).
Discussion
Our study demonstrates the presence of MAPK isoforms p44 ERK1 and p42 ERK2 in human red blood cell. These kinases were activated by insulin and okadaic acid. The insulin-induced MAPK activation seems to be transient, returning to basal levels at 10 min. This e¡ect was completely abolished by PD98059, a speci¢c inhibitor of MEK, the MAPK activator. The activation of MAPK by insulin regulates NHE activity, suggesting a possible link between insulin signaling, MAPK stimulation and NHE-1 activity in insulin-independent red blood cells. This pathway has been already investigated in insulin-dependent cells.
MAPK, a family of ubiquitous Ser/Thr kinases, plays an important role in various signal transduction pathways [13] . The activation of MAPK family is regulated by phosphorylation of tyrosine and threonine residues, both of which are necessary for enzyme activity. Once activated, MAPK are responsible for the phosphorylation and activation of other downstream kinases and regulatory proteins [18] . In particular, two members of this family, the extracellular related kinases 1 (p44 ERK1 ) and 2 (p42 ERK2 ) are involved in the intracellular signaling following insulin stimulation [19] . Recently, it has been shown that MAPK is involved in erythropoietin-induced di¡er-entiation. In fact, in human erythroid-forming cells Fig. 4 . MAPK activity after insulin stimulation (100 nM for 3 min) in the absence (middle bar) and in the presence of PD98059 (right bar). MAPK activity (mean þ S.E., n = 11) was determined as described in Section 2. **P 6 0.01 versus control condition. Fig. 3 . Time course of MAPK activation by insulin. MAPK activity (mean þ S.E.) was determined at baseline (0 min) and in the presence of insulin (100 nM) for 1, 2, 3, 5 and 10 min, as described in Section 2. Fig. 5 . MAPK activity after okadaic acid exposure in the absence (middle bar) and in the presence of PD98059 (right bar). MAPK activity (mean þ S.E., n = 5) was determined as described in Section 2. OA, okadaic acid. **P 6 0.01 versus control condition.
erythropoietin and stem cell factor synergistically activate p44 ERK1 and p42 ERK2 [20] . To our knowledge, this is the ¢rst study that documents the presence of p44 ERK1 and p42 ERK2 in human circulating RBC suggesting that MAPK is present not only in staminal hematopoietic cell, but in all the circulating elements, including RBC and platelets [11] . Although in RBC the physiologic function of MAPK is not clear, our results suggest a potential role of MAPK in the signal transduction mechanisms of these cells.
Insulin receptors have been identi¢ed in human RBC [21] . They are about 2000 per erythrocyte, but their function is still unclear. Furthermore, the presence of Ras, a downstream element of the insulin receptor-activated cascade, has already been documented in human RBC [22] .
Several studies have shown that p44 ERK1 and p42 ERK2 are activated by insulin through a Ras-dependent mechanism [19] . Ras is activated by the translocation of Sos to the plasma membrane due to the tyrosine-phosphorylation of Grb2 or IRS-1. Activated Ras recruits RAF which is responsible for phosphorylation and activation of MEK, the upstream kinase of the ERK cascade [23] .
In the current study, we demonstrated that in RBC, MAPK is activated by insulin. Phosphorylation of MAPK peaked at 3 min, and its activation was inhibited by PD98059, a speci¢c MEK inhibitor, at the concentration used in our experiments [24] . The activation of MAPK by insulin is transient, probably due to rapid dephosphorylation of the threonine and tyrosine residues by protein phosphatases. In fact, RBC contain a large amount of constitutively active phosphatases [15] .
Furthermore, we evaluated the e¡ect of okadaic acid, a serine/threonine protein phosphatase inhibitor, on MAPK activation. Okadaic acid induces a marked increase of serine/threonine residue phosphorylation of various RBC proteins, whereas it does not a¡ect serine/threonine^protein kinase activity [25] . We found that okadaic acid stimulates MAPK activity whose e¡ect is completely abolished by PD98059, suggesting that the latter does not act directly on MAPK, but on MEK or other upstream activators of MAPK activated by RBC phosphatases inhibition.
It has been shown that MAPK cascade is involved in NHE-1 regulation in eukaryotic cell [26] . Pontremoli et al. reported that insulin and okadaic acid increase NHE activity in human RBC [27] . Our data con¢rm that insulin stimulates NHE activity in RBC. Furthermore, we demonstrate the insulin receptor signaling cascade (i.e. phosphorylation of p44 ERK1 and p42 ERK2 , activation of MAPK activity, activation of NHE) in human RBC. These e¡ects Fig. 6 . E¡ects of insulin and okadaic acid on NHE activity, with and without PD98059. NHE activity (mean þ S.E.) was determined as described in Section 2. OA, okadaic acid. *P 6 0.05 versus control conditions. were inhibited by PD98059, suggesting a direct linkage between NHE activation and MAPK. MAPK probably does not directly phosphorylate NHE-1 [2, 10] . Therefore, we hypothesized the existence of other intracellular downstream kinases, capable of phosphorylating the NHE-1.
In conclusion, we found that MAPK isoforms p44 ERK1 and p42 ERK2 play a role in the activation of NHE-1 in human RBC following insulin stimulation. This might account for the correlation between insulin-resistance and cation heteroexchange activity (sodium^proton and sodium^lithium exchange). Further studies are needed to better elucidate such a correlation which is common in patients with essential hypertension [28] .
